» Articles » PMID: 2991570

Specificities of Monoclonal and Polyclonal Antibodies That Inhibit Adsorption of Herpes Simplex Virus to Cells and Lack of Inhibition by Potent Neutralizing Antibodies

Overview
Journal J Virol
Date 1985 Aug 1
PMID 2991570
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

Polyclonal and monoclonal antibodies to individual herpes simplex virus (HSV) glycoproteins were tested for ability to inhibit adsorption of radiolabeled HSV type 1 (HSV-1) strain HFEMsyn [HSV-1(HFEM)syn] to HEp-2 cell monolayers. Polyclonal rabbit antibodies specific for glycoprotein D (gD) or gC and three monoclonal mouse antibodies specific for gD-1 or gC-1 most effectively inhibited HSV-1 adsorption. Antibodies of other specificities had less or no inhibitory activity despite demonstrable binding of the antibodies to virions. Nonimmune rabbit immunoglobulin G and Fc fragments partially inhibited adsorption when used at relatively high concentrations. These results suggest involvement of gD, gC, and perhaps gE (the Fc-binding glycoprotein) in adsorption. The monoclonal anti-gD antibodies that were most effective at inhibiting HSV-1 adsorption had only weak neutralizing activity. The most potent anti-gD neutralizing antibodies had little effect on adsorption at concentrations significantly higher than those required for neutralization. This suggests that, although some anti-gD antibodies can neutralize virus by blocking adsorption, a more important mechanism of neutralization by anti-gD antibodies may be interference with a step subsequent to adsorption, possibly penetration.

Citing Articles

IgA Vasculitis: Etiology, Treatment, Biomarkers and Epigenetic Changes.

Sugino H, Sawada Y, Nakamura M Int J Mol Sci. 2021; 22(14).

PMID: 34299162 PMC: 8307949. DOI: 10.3390/ijms22147538.


Out of Sight, but Not Out of Mind: Aspects of the Avian Oncogenic Herpesvirus, Marek's Disease Virus.

Davidson I Animals (Basel). 2020; 10(8).

PMID: 32751762 PMC: 7459476. DOI: 10.3390/ani10081319.


Broad-spectrum inhibition of HIV-1 by a monoclonal antibody directed against a gp120-induced epitope of CD4.

Burastero S, Frigerio B, Lopalco L, Sironi F, Breda D, Longhi R PLoS One. 2011; 6(7):e22081.

PMID: 21818294 PMC: 3139607. DOI: 10.1371/journal.pone.0022081.


Separation of decay-accelerating and cofactor functional activities of Kaposi's sarcoma-associated herpesvirus complement control protein using monoclonal antibodies.

Mark L, Proctor D, Blackbourn D, Blom A, Spiller O Immunology. 2007; 123(2):228-38.

PMID: 17764451 PMC: 2433302. DOI: 10.1111/j.1365-2567.2007.02692.x.


Pseudotyping of glycoprotein D-deficient herpes simplex virus type 1 with vesicular stomatitis virus glycoprotein G enables mutant virus attachment and entry.

Anderson D, Laquerre S, Ghosh K, GHOSH H, Goins W, Cohen J J Virol. 2000; 74(5):2481-7.

PMID: 10666285 PMC: 111736. DOI: 10.1128/jvi.74.5.2481-2487.2000.


References
1.
Nahmias A, KIBRICK S . Inhibitory effect of heparin on herpes simplex virus. J Bacteriol. 1964; 87(5):1060-6. PMC: 277146. DOI: 10.1128/jb.87.5.1060-1066.1964. View

2.
Porter R . The hydrolysis of rabbit y-globulin and antibodies with crystalline papain. Biochem J. 1959; 73:119-26. PMC: 1197021. DOI: 10.1042/bj0730119. View

3.
Spear P, Roizman B . Proteins specified by herpes simplex virus. V. Purification and structural proteins of the herpesvirion. J Virol. 1972; 9(1):143-59. PMC: 356272. DOI: 10.1128/JVI.9.1.143-159.1972. View

4.
Sim C, Watson D . The role of type specific and cross reacting structural antigens in the neutralization of herpes simplex virus types 1 and 2. J Gen Virol. 1973; 19(2):217-33. DOI: 10.1099/0022-1317-19-2-217. View

5.
Honess R, Watson D . Herpes simplex virus-specific polypeptides studied by polyacrylamide gel electrophoresis of immune precipitates. J Gen Virol. 1974; 22(2):171-85. DOI: 10.1099/0022-1317-22-2-171. View